Tirzepatide, a innovative medication, is sparking considerable buzz within the scientific community. It operates differently from existing diabetes medications, targeting both receptors involved in sugar regulation and hunger . Initial research have demonstrated remarkable efficacy in controlling blood levels in individuals with type 2 diabetes and